Industry Newsroom

ChrysCapital Acquires 3% Stake in Indian Pharma Intas for USD132m, Capital International Exits

ChrysCapital has acquired an additional 3% stake in India-based pharmaceutical company Intas for USD132m, providing an exit for Capital International. ChrysCapital originally invested in Intas in 2006, and the current investment brings its stake in the company to 6%. Read more